Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

WX-G250 shows antitumor activity and very good tolerance in RCC

Feb. 25, 2002

Scancell develops apoptosis-inducing and anti-growth factor antibodies

Feb. 25, 2002

Orphan drug status granted for SS1-PE38 in mesothelioma and ovarian cancer

Feb. 19, 2002

Hollis-Eden collaborating on development of Aeson's lead compound

Feb. 19, 2002

Compounds that enhance transcription factor AP-1 designed at Active Biotech

Feb. 18, 2002

Phase II trial of CeaVac and TriAb initiated in metastatic colorectal cancer

Feb. 12, 2002

Biomira initiates phase II trial of Theratope vaccine in metastatic colorectal cancer

Feb. 11, 2002

SciClone updates progress of Zadaxin

Feb. 11, 2002

MCA approves phase II study of TTS in pancreatic cancer

Feb. 7, 2002

Fast track designation for Oncophage in metastatic melanoma

Feb. 6, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...